Tau Assembly in inducible transfectants expressing wild-type or FTDP-17 tau

American Journal of Pathology

Volumn 161, Issue 5, 2002, Pages 1711-1722

  DeTure, Michael ^a   Ko, Li wen ^a   Easson, Colin ^a   Yen, Shu Hui ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; SODIUM CHLORIDE; TAU PROTEIN; TYLOXAPOL;

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 17; CYTOPLASM; FRONTOTEMPORAL DEMENTIA; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MICROSCOPY; MICROTUBULE; MISSENSE MUTATION; NEUROFIBRILLARY TANGLE; PARKINSONISM; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 0036841609     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64448-3     Document Type: Article

References (41)

1. Spillantini MG, Van Swieten JC, Goedert M: Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2000, 2:193-205
2. Heutink P: Untangling tau-related dementia. Hum Mol Genet 2000, 9:979-986
3. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD: Relative roles of plaques and tangles in the dementia of Alzheimer's disease: Correlations using three sets of neuropathological criteria. Dementia 1995, 6:21-31
4. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hacket J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaf E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Kuei Che L, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd P, Hayward N, Kwok BJ, Schofield P, Andreadis A, Snowden J, Craufurd D, Neary D, Owen, Oostr B, Hardy J, Goate A, Van Swieten J, Mann D, Lynch T, Heutink P: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705
5. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD: Tau is a candidate gene for chromosome 17 frontotemporal dementia Ann Neurol 1998, 43:815-825
6. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998, 95:7737-7741
7. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M: Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000, 25:402-405
8. Gotz J, Chen F, Barmettler R, Nitsch RM: Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2000, 276:529-534
9. Furukawa K, D'Souza I, Crudder CH, Onodera H, Itoyama Y, Poorkaj P, Bird TD, Schellenberg GD: Pro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism. Neuroreport 1999, 11:57-60
10. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J. Hutton M, Feany MB: Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles. Science 2001, 293:711-714
11. Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A: Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 1988, 85:4506-4510
12. Nagiec EW, Sampson KE, Abraham I: Mutated tau binds less avidly to microtubules than wildtype tau in living cells. J Neurosci Res 2001, 63:268-275
13. Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, Hutton M, Yen SH: Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett 1999, 447:195-199
14. Goedert M, Jakes R, Crowther RA: Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett 1999, 450:306-311
15. Gamblin TC, King ME, Dawson H, Vitek MP, Kuret J, Berry RW, Binder LI: In vitro polymerization of tau protein monitored by laser light scattering: Method and application to the study of FTDP-17 mutants. Biochemistry 2000, 39:6136-6144
16. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski JQ, Lee VM: Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological pheno-types in transfected CHO cells. Mol Biol Cell 2000, 11:4093-4104
17. Alonso AC, Grundke-Iqbal, Iqbal K: Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 1996, 2:783-787
18. Alonso A, Grundke-Iqbal I, Barra HS, Iqbal K: Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Nat Acad Sci USA 1997, 94:298-303
19. Connell JW, Gibb GM, Betts JC, Blackstock WP, Gallo J, Lovestone S, Hutton M, Anderton BH: Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes. FEBS Lett 2001, 493:40-44
20. Miyasaka T, Morishima-Kawashima M, Ravid R, Heutink P, van Swieten JC, Nagashima K, Ihara Y: Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. Am J Pathol 2001, 158:373-379
21. Perez M, Lim F, Arrasate M, Avila J: The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules. J Neurochem 2000, 74:2583-2589
22. Sahara N, Tomiyama T, Mor HJ: Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: A novel action of R406W mutation. J Neurosci Res 2000, 60:380-387
23. Frappier T, Liang NS, Brown K, Leung CL, Lynch T, Liem RK, Shelanski ML: Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation. FEBS Lett 1999, 455: 262-266
24. Matsumura N, Yamazaki T, Ihara Y: Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am J Pathol 1999, 154:1649-1656
25. Perez M, Hernandez F. Gomez-Ramos A, Smith M, Perry G, Avila J: Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. FEBS Lett 2002, 269:1484-1489
26. Dickson DW: Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999, 246:6-15
27. Kenessey A, Nacharaju P, Ko LW, Yen SH: Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration J Neurochem 1997, 69:2026-2038
28. Yen SH, Fields KL: Antibodies to neurofilament glial filament and fibroblast intermediate filament proteins to different cell types of the nervous system. J Cell Biol 1981, 88:115-126
29. Schweers O, Mandelkow EM, Biernat J, Mandelkow E: Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci USA 1995, 92:8463-8467
30. DeTure M, Ko L, Easson C, Hutton M, Yen SH: Inducible expression of wild type tau in H4 neuroglioma cells. Alzheimer's Disease: Advance in Etiology, Pathogenesis and Therapeutics. Edited by K Iqbal, SS Sisodia, B Winblad. New York, John Wiley & Sons Ltd., 2001, pp 6651-6660
31. Ksiezak-Reding H, Liu W-K, Wall JS, Yen SH: Biochemical isolation and characterization of paired helical filaments. Function and Malfunction of the Tau Proteins: Concepts and Approaches. Edited by R Brandt, J Avila, K Kosik. Harwood Academic Publisher, Newark, NJ, 1997, pp 651-660
32. Arawaka S, Usami M, Sahara N, Schellenberg GD, Lee G, Mori H: The tau mutation (val337met) disrupts cytoskeletal networks of microtubules. Neuroreport 1999, 10:993-997
33. Dayanandan R, Van Slegtenhorst M, Mack TG, Ko L, Yen SH, Leroy K, Brion JP, Anderton BH, Hutton M, Lovestone S: Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett 1999, 12:228-232
34. Jicha GA, Berenfeld B, Davies P: Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J Neurosci Res 1999, 55:713-723
35. Daly NL, Hoffmann R, Otvos Jr L, Craik DJ: Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. Biochemistry 2000, 39:9039-9046
36. Carmel G, Mager EM, Binder LI, Kuret J: The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 1996, 271:32789-32795
37. Jicha GA, Rockwood JM, Berenfeld B, Hutton M, Davies P: Altered conformation of recombinant frontotemporal dementia-17 mutant tau. Neurosci Lett 1996, 260:153-156
38. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC. Schellenberg GD, Trojanowski JQ, Lee VMY: Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998, 282:1914-1917
39. Hasegawa M, Smith MJ, Goedert M: FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett 1998, 437:207-210
40. DeTure M, Ko L, Yen S, Nacharaju P, Easson C, Lewis J, van Slegtenhorst M, Hutton M, Yen SH: Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res 2000, 853:5-14
41. Lu M, Kosik KS: Competition for microtubule-binding with dual expression of tau missense and splice isoforms. Mol Biol Cell 2001, 12:171-184